New Desktop SEM from Thermo Fisher Scientific Helps Manufacturers Improve Quality Control, Production Efficiency and Material Cleanliness

HILLSBORO, Ore., Sept. 18, 2019 /PRNewswire/ — Thermo Fisher Scientific today introduced the Thermo Scientific Phenom ParticleX, a versatile and intuitive desktop scanning electron microscope (SEM) solution that is designed to provide automotive suppliers and additive manufacturing companies faster quality control analyses of materials used in development and production. The Phenom ParticleX includes a broad range of automated SEM analyses to identify faults in materials or gauge the impact development and production changes have on a final product. By keeping quality control in-house, Phenom ParticleX users can analyze materials up to ten times faster than outsourcing.

“Obtaining timely information is a prerequisite for lean manufacturing and the new automated system in the Phenom ParticleX offers multiple sample analyses, including chemical and morphological classification, outlier detection, and identification of contamination that allow users to validate produced goods against industry-approved standards,” said Trisha Rice, vice president and general manager of materials science at Thermo Fisher Scientific. “Fast validation time enables manufacturing companies to meet customer commitments while requiring less inventory.”

The high-resolution imaging and chemical analysis capabilities in the Phenom ParticleX deliver more detailed failure analyses than is possible using optical microscopes. Additive manufacturers can characterize size distribution, particle homogeneity and foreign contaminants to evaluate the purity of metal particles at the microscale. Industrial manufacturers can use it to confirm whether components fulfill technical cleanliness specifications according to the VDA19 or ISO16232 standards. It also provides detailed feedback on the cleanliness or purity of final product without the manufacturer having to share this confidential and valuable data with third parties.

The Phenom ParticleX package consists of a high-performance Phenom XL Desktop SEM with automation software packages for additive manufacturing and technical cleanliness. More information can be found at: thermofisher.com/phenom-particle-x.

About Thermo Fisher Scientific

Thermo Fisher Scientific is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit thermofisher.com.

Media Contact Information: 
Kathy Gill 
Thermo Fisher Scientific 
+1 971-294-9262 
kathy.gill@thermofisher.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/new-desktop-sem-from-thermo-fisher-scientific-helps-manufacturers-improve-quality-control-production-efficiency-and-material-cleanliness-300921045.html

SOURCE Thermo Fisher Scientific

Staff

Recent Posts

Dimora Medical Recognized as Key Driver in Winner Medical’s Amazon Award

NEW YORK, Dec. 9, 2025 /PRNewswire/ -- Winner Medical, the parent company of Dimora Medical, has…

7 minutes ago

BioNxt Advances “Melt in Your Mouth” Cladribine Formulation to Improve Treatment for MS Patients with Dysphagia

VANCOUVER, BC / ACCESS Newswire / December 9, 2025 / BioNxt Solutions Inc. ("BioNxt" or…

7 minutes ago

CGTN: In the wake of tragedy, Hong Kong comes together to rebuild

BEIJING, Dec. 8, 2025 /PRNewswire/ -- CGTN published an article on the post-disaster rescue and…

6 hours ago

The Jackson Laboratory receives an up to $30 million contract award to revolutionize drug safety testing with AI-powered “virtual hearts”

New CARDIOVERSE project combines AI, stem cells, and genetic variation to predict drug safety before…

6 hours ago

Bausch Health Announces Early Exchange Offer Results for Exchange Offers

LAVAL, QC / ACCESS Newswire / December 8, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC)…

9 hours ago

Rapid Dose Completes Extension to Promissory Notes

Burlington, Ontario--(Newsfile Corp. - December 8, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the…

10 hours ago